“I’ve been working with Alessandro for quite some time and he is one of the few that really can make a difference for both companies looking for key personnel, as well as individuals looking for new opportunities. In both cases a positive experience. I would therefore recommend Alessandro and Mantell Associates.”
Chief Strategy Officer, Nuvisan
“I couldn’t be happier with my experience with Mantell Associates. Their team provided exceptional support and guidance throughout the entire job search process. They were always available to answer my questions and offered invaluable advice that helped me feel confident and prepared for my future role. Their personalised approach made me feel truly accompanied every step of the way. Thanks to their expertise, I secured a job that aligns perfectly with my career goals. Highly recommend!”
Business Development Director – Drug Discovery, Nuvisan
Founded in Europe with more than 40 years of experience, Nuvisan is a fully integrated contract research and development, and manufacturing organisation (CRO/CDMO) that offers unique, high-quality, and tailored integrated solutions along the drug discovery and development value chain.
Nuvisan, a formerly independent, family-owned CRO has grown significantly over the years and has expanded its services and capabilities to meet the changing needs of its clients. Operating under the name Nuvisan since 2010, ALS Limited, the global leader in testing, acquired Nuvisan on April 1, 2024, forming the most advanced drug discovery and development organisation and providing solutions across continents.
They the following portfolio of services:
- Target Identification and Validation
- Target-to-Lead
- Lead-to-Candidate
- Preclinical
- Clinical
Company website – https://www.nuvisan.com/home
To find out more about Nuvisan, contact Thomas White on +44 (0)20 3854 7700 or thomas.white@mantellassociates.com.